Alexander Kapp

Q: What Schools Are Affiliated With Alexander Kapp

Alexander Kapp is affiliated with the following schools: University of Freiburg, Hannover Medical School, Technical University of Berlin, Heidelberg University

Alexander Kapp 's AcademicInfluence.com Rankings

Alexander Kapp

Computer Science

#5037

World Rank

#5323

Historical Rank

Machine Learning

#1185

World Rank

#1205

Historical Rank

Artificial Intelligence

#1418

World Rank

#1447

Historical Rank

Database

#2204

World Rank

#2319

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Alexander Kapp Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Alexander Kapp is a German dermatologist and allergist. He was chairman and medical director of the department of dermatology and allergy at the Hannover Medical School until his retirement in 2022. He is known for his work in the field of pathophysiology of inflammatory skin diseases , his research on neuro-immunological interactions in allergic inflammation and on the role of eosinophilic granulocytes in allergy and dermatology.

(See a Problem?)

Alexander Kapp 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. (2014) (1106)
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria (2018) (1014)
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria (2006) (690)
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. (2006) (469)
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria (2009) (462)
EAACI/GA2LEN/EDF guideline: management of urticaria (2006) (451)
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. (2012) (445)
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2006) (434)
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. (2006) (404)
Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis (2000) (372)
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update (2015) (348)
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. (2010) (335)
Labor und Diagnose (2000) (311)
Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis (2002) (307)
Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis (2005) (294)
Evidence that Singlet Oxygen-induced Human T Helper Cell Apoptosis Is the Basic Mechanism of Ultraviolet-A Radiation Phototherapy (1997) (279)
Correlation of IL-31 serum levels with severity of atopic dermatitis. (2008) (271)
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study (2006) (266)
High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. (1992) (261)
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. (2002) (253)
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria (2006) (241)
Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. (1996) (230)
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. (1998) (206)
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. (2008) (196)
Human eotaxin represents a potent activator of the respiratory burst of human eosinophils (1996) (191)
MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma (2010) (191)
Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. (1999) (189)
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria (2021) (188)
Late eczematous reactions to food in children with atopic dermatitis (2004) (186)
The role of eosinophils in the pathogenesis of atopic dermatitis ‐ eosinophil granule proteins as markers of disease activity (1993) (183)
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. (1994) (176)
C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils (1994) (174)
Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis (1992) (166)
Urticaria and infections (2009) (165)
Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. (1991) (165)
Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB) (2000) (160)
Prevalence of Helicobacter pylori–Associated Gastritis in Chronic Urticaria (1998) (156)
Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. (1997) (149)
Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas (2008) (144)
Environmental and other major provocation factors in atopic dermatitis (1998) (143)
Chronic urticaria and infections (2004) (141)
Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis (2005) (141)
Colonoscopic allergen provocation (COLAP): a new diagnostic approach for gastrointestinal food allergy. (1997) (140)
Activated Human T Lymphocytes Express a Functional C3a Receptor1 (2000) (135)
IL‐31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis (2012) (134)
Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs. (2000) (134)
The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3 (1997) (130)
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. (2015) (130)
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. (1998) (125)
Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. (2005) (122)
The hand‐foot‐syndrome associated with medical tumor therapy – classification and management (2010) (117)
Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. (1997) (115)
C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. (1999) (114)
Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. (2001) (113)
Investigation of contact allergy to dental metals in 206 patients (2009) (113)
The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. (1994) (109)
Bacterial infections and atopic dermatitis (2001) (109)
Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. (1990) (106)
Physical urticaria: classification and diagnostic guidelines (1997) (105)
Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining (2001) (104)
Allergy, Asthma & Clinical Immunology (2009) (103)
The role of circulating food antigen‐specific lymphocytes in food allergic children with atopic dermatitis (1996) (100)
Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis (1988) (99)
Aluminium‐induced granulomas after inaccurate intradermal hyposensitization injections of aluminium‐adsorbed depot preparations (2000) (98)
Photodynamic Therapy With Methyl Aminolevulinate for Prevention of New Skin Lesions in Transplant Recipients: A Randomized Study (2008) (96)
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. (1993) (95)
The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis (1993) (95)
Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. (1999) (95)
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study (2009) (95)
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. (2000) (93)
Helicobacter pylori Infection in Skin Diseases (2002) (92)
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. (2001) (91)
Circulating levels of brain‐derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis (2006) (91)
Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. (1996) (91)
Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 (2020) (90)
Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Childhood Atopic Dermatitis (2005) (89)
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. (2014) (87)
The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. (1999) (87)
Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. (1993) (86)
Differential Activation of CC Chemokine Receptors by AOP-RANTES* (2000) (85)
Alpha‐toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis (2005) (85)
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study (2009) (84)
55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. (1991) (83)
Eosinophil cationic protein in sera of patients with atopic dermatitis. (1991) (83)
Stress-Induced Endocrine and Immunological Changes in Psoriasis Patients and Healthy Controls (1998) (81)
Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma (2002) (80)
Dysregulation of toll‐like receptor‐2 (TLR‐2)‐induced effects in monocytes from patients with atopic dermatitis: impact of the TLR‐2 R753Q polymorphism (2008) (78)
Birch pollen‐related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome (2004) (77)
Actin polymerization. (2000) (77)
[Topical skin therapy with glucocorticoids--therapeutic index]. (2004) (76)
Helicobacter pylori infection in skin diseases: a critical appraisal. (2002) (76)
Eosinophil apoptosis is mediated by stimulators of cellular oxidative metabolisms and inhibited by antioxidants: involvement of a thiol-sensitive redox regulation in eosinophil cell death. (1999) (76)
Increased levels of serum IL‐31 in chronic spontaneous urticaria * (2010) (75)
Sentinel lymph node status is the most important prognostic factor for thick (≥ 4 mm) melanomas (2008) (74)
Human basophils are a source of ‐ and are differentially activated by ‐ IL‐31 (2017) (74)
Bioluminescence and chemiluminescence - new perspectives (1987) (74)
S2k guideline on diagnosis and treatment of atopic dermatitis – short version (2016) (73)
Human Dendritic Cells Express the IL-18R and Are Chemoattracted to IL-18 1 (2003) (72)
Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities (2008) (71)
Milk-responsive atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients (1997) (70)
microRNA‐21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells (2012) (70)
Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy (2005) (70)
Ultraviolet Radiation Effects on Human Keratinocyte ICAM-1 Expression: UV-Induced Inhibition of Cytokine-Induced ICAM-1 mRNA Expression Is Transient, Differentially Restored for IFNγ Versus TNFÎ±, and Followed by ICAM-1 Induction Via a TNFÎ±-Like Pathway (1992) (70)
Regulation and modulation of eosinophil effector functions (1999) (69)
Anal Mucosal Melanoma with KIT-Activating Mutation and Response to Imatinib Therapy – Case Report and Review of the Literature (2009) (68)
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy. (2013) (68)
Prognostic Significance of Isolated HMB45 or Melan A Positive Cells in Melanoma Sentinel Lymph Nodes (2007) (67)
Effective treatment of refractory severe heat urticaria with omalizumab (2009) (67)
Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. (2004) (66)
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients (2009) (66)
Sentinel node biopsy in melanoma delays recurrence but does not change melanoma‐related survival: a retrospective analysis of 673 patients (2005) (66)
Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. (1997) (66)
Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. (2001) (65)
Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. (1993) (65)
Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled, parallel, multicenter study (2006) (64)
S2k guideline on diagnosis and treatment of atopic dermatitis — short version (2016) (64)
Eotaxin‐2 activates chemotaxis‐related events and release of reactive oxygen species via pertussis toxin‐sensitive G proteins in human eosinophils (1998) (64)
Dynamic changes in nevi of a patient with melanoma treated with vemurafenib: importance of sequential dermoscopy. (2012) (64)
Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate‐induced contact dermatitis (1992) (64)
A topic dermatitis the skin manifestation of a topic (1995) (63)
Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients. (2013) (63)
Human monocyte‐derived dendritic cells are chemoattracted to C3a after up‐regulation of the C3a receptor with interferons (2004) (62)
Neuroimmunological findings in allergic skin diseases (2005) (61)
Detection of a κ‐casein‐specific lymphocyte response in milk‐responsive atopic dermatitis (1996) (60)
Therapy of noninfectious granulomatous skin diseases with fumaric acid esters (2005) (59)
Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanoma (2011) (59)
The incidence of atopic dermatitis in school entrants is associated with individual life‐style factors but not with local environmental factors in Hannover, Germany (2002) (58)
IL-4-induced apoptosis in peripheral blood eosinophils. (1998) (58)
Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions (1997) (58)
Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. (2002) (58)
Soluble E‐selectin in sera of patients with atopic dermatitis and psoriasis—correlation with disease activity (1996) (56)
Management of childhood urticaria: current knowledge and practical recommendations. (2013) (56)
IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31. (2015) (56)
Mechanisms of human eosinophil activation by complement protein C5a and platelet‐activating factor: similar functional responses are accompanied by different morphologic alterations (1995) (55)
Akuttherapie anaphylaktischer Reaktionen (2007) (55)
Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin (2001) (54)
The diagnosis and graded therapy of atopic dermatitis. (2014) (54)
The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function (2020) (53)
Rapid identification and differentiation of fungal DNA in dermatological specimens by LightCycler PCR. (2004) (53)
Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. (1986) (52)
IL-3 Induces Down-Regulation of CCR3 Protein and mRNA in Human Eosinophils1 (2001) (52)
Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells. (1988) (52)
Human granulocyte-macrophage colony stimulating factor: an effective direct activator of human polymorphonuclear neutrophilic granulocytes. (1988) (52)
Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. (1998) (51)
Criteria in Sentinel Lymph Nodes of Melanoma Patients that Predict Involvement of Nonsentinel Lymph Nodes (2008) (49)
Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid. (2018) (49)
Human tumor necrosis factor is a potent activator of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: comparison with human lymphotoxin. (1989) (49)
Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: the role of immuno-modulating cytokines. (1990) (48)
Neurodermitis S2‐Leitlinie (2009) (48)
Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis (2008) (48)
Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. (2002) (47)
No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients (2006) (47)
Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris (2000) (46)
Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides (1987) (46)
Blood‐ and skin‐derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin‐sensitive signal transduction pathway (1997) (45)
Differential up‐regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects (2008) (45)
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low‐dose interferon alpha (2007) (45)
Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. (2000) (45)
Suppression of IL-12 Production by Soluble CD40 Ligand: Evidence for Involvement of the p44/42 Mitogen-Activated Protein Kinase Pathway1 (2002) (44)
Sensitive Detection of Borrelia burgdorferi Sensu Lato DNA and Differentiation ofBorrelia Species by LightCycler PCR (2001) (43)
Retiform hemangioendothelioma: another tumor associated with human herpesvirus type 8? (2000) (41)
Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry (2002) (41)
Staphylococcus aureus‐derived enterotoxins enhance house dust mite‐induced patch test reactions in atopic dermatitis (2007) (40)
Comparison of classification systems in melanoma sentinel lymph nodes—An analysis of 697 patients from a single center (2010) (40)
Non‐melanoma skin cancer is reduced after switch of immunosuppression to mTOR‐inhibitors in organ transplant recipients (2014) (40)
Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. (1993) (40)
Cutaneous side effects of new antitumor drugs: clinical features and management. (2012) (40)
Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma (2000) (39)
Neurotrophins in healthy and diseased skin. (2010) (39)
The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions (1999) (39)
CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. (1996) (38)
Suppression of Interleukin-12 Production by Human Monocytes After Preincubation With Lipopolysaccharide (1999) (38)
/ GA 2 LEN / EDF / WAO guideline for the definition , classification , diagnosis and management of urticaria (2018) (38)
Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node? (2014) (38)
Chronic urticaria: clinical aspects and focus on a new antihistamine, levocetirizine. (2004) (37)
Milk-responsive atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients. (1997) (37)
Substance P activates human eosinophils (2015) (36)
Unilateral laterothoracic exanthem (asymmetrical periflexural exanthem of childhood): report of an adult patient. (1997) (35)
Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti‐C5a receptor (CD88) antibodies (1996) (35)
Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies (2002) (35)
TNFα‐induced activation of eosinophil oxidative metabolism and morphology ‐ Comparison with IL‐5 * (1994) (34)
Sentinel Node Dissection Delays Recurrence and Prolongs Melanoma-Related Survival: An Analysis of 673 Patients from a Single Center with Long-Term Follow-Up (2011) (34)
Helicobacter pylori infection and skin diseases. (1999) (34)
Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age (2001) (34)
Influence of Pimecrolimus Cream 1% on Different Morphological Signs of Eczema in Infants with Atopic Dermatitis (2004) (33)
Activation of the respiratory burst in human eosinophils by chemotaxins requires intracellular calcium fluxes. (1995) (33)
The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils (1999) (33)
Release of sulfidoleukotrienes in vitro: Its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid (1995) (32)
Cost Effectiveness of Levocetirizine in Chronic Idiopathic Urticaria (2006) (32)
Characterization of the CC chemokine receptor 3 on human keratinocytes. (2001) (31)
Actin polymerization in human eosinophils, unlike human neutrophils, depends on intracellular calcium mobilization. (1996) (30)
Characterization of Synthetic C3a Analog Peptides on Human Eosinophils in Comparison to the Native Complement Component C3a1 (2000) (30)
The role of cytokines in the psoriatic inflammation. (1993) (30)
Pyoderma gangraenosum Erfolgreiche topische Therapie mit Tacrolimus (FK506) (2001) (29)
Atopic dermatitis management with tacrolimus ointment (Protopic®) (2003) (29)
Human epidermal keratinocytes are a source of soluble ICAM‐1 molecules * (1992) (29)
What do we know about the etiopathology of the intrinsic type of atopic dermatitis? (1999) (28)
The CC chemokine receptor 3 CCR3 is functionally expressed on eosinophils but not on neutrophils (2000) (28)
Imiquimod 5% Cream in the Treatment of Human Papillomavirus-16-Positive Erythroplasia of Queyrat (2002) (28)
S2k‐Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion (2016) (27)
Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005. (2006) (27)
Neuronal branching of sensory neurons is associated with BDNF‐positive eosinophils in atopic dermatitis (2020) (27)
Neurophysiologie des Pruritus (2006) (27)
Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels. (1991) (27)
Enhanced endogenous leukotriene biosynthesis in patients treated with granulocyte-macrophage colony-stimulating factor. (1990) (27)
Actin polymerization in human eosinophils, unlike human neutrophils, depends on intracellular calcium mobilization (1996) (27)
Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway. (1992) (26)
Tumoral melanosis involving the sentinel lymph nodes: a case report (2007) (26)
Modulation of intercellular adhesion molecule 1 (ICAM‐1) expression on the human mast‐cell line (HMC)‐1 by inflammatory mediators (1996) (26)
Activation of human eosinophils by chemokines. (2000) (26)
Up‐regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2 (2003) (26)
Neurological disorders are associated with bullous pemphigoid (2019) (26)
Allergic manifestations of skin diseases--atopic dermatitis. (2006) (26)
Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide. (1999) (26)
Granulocyte-activating mediators (GRAM): I. Generation by lipopolysaccharide-stimulated mononuclear cells. (1986) (26)
Immunomodulating cytokines in atopic dermatitis and psoriasis: production of tumour necrosis factor and lymphotoxin by mononuclear cells in vitro (1990) (25)
Synthesis and surface expression of ICAM-1 in polymorphonuclear neutrophilic leukocytes in normal subjects and during inflammatory disease. (1995) (25)
The impact of oral vitamin A derivatives on lipid metabolism – What recommendations can be derived for dealing with this issue in the daily dermatological practice? (2011) (25)
Contact allergy to dental materials (2012) (25)
IgE autoantibodies in atopic dermatitis ‐occurrence of different antibodies against the CH3 and the CH4 epitopes of IgE (1995) (24)
Akuttherapie anaphylaktischer Reaktionen Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umwelt- medizin (GPA) und der Deutschen Akademie für Allergologie und (2007) (24)
Intracutaneous injection of the macrophage‐activating lipopeptide‐2 (MALP‐2) which accelerates wound healing in mice – a phase I trial in 12 patients (2008) (24)
Altered production of immuno-modulating cytokines in patients with atopic dermatitis. (1989) (24)
Detection of clonal T cell receptor gamma gene rearrangements in cutaneous T cell lymphoma by LightCycler-polymerase chain reaction. (2001) (23)
Significant Delay of Apoptosis and Fas Resistance in Eosinophils of Subjects with Intrinsic and Extrinsic Type of Atopic Dermatitis (1999) (23)
Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone. (2012) (23)
Involvement of complement in psoriasis and atopic dermatitis — Measurement of C3a and C5a, C3, C4 and C1 inactivator (2004) (23)
Aspirin induced adverse skin reactions: new pathophysiological aspects (2000) (23)
Diagnostics of autoimmune bullous diseases in German dermatology departments (2012) (22)
Kutane Nebenwirkungen einer EGF-Rezeptor-Blockade und deren Management (2006) (22)
Interleukin‐5‐induced granulocyte activation in atopic patients (1991) (21)
Pathophysiological role of leukotrienes in dermatological diseases: potential therapeutic implications. (2001) (21)
Successful Therapy of Annular Elastolytic Giant Cell Granuloma with Fumaric Acid Esters (2002) (21)
Allergic contact dermatitis to acid blue 158 in suture material (2008) (21)
[Atopic dermatitis: S2 guidelines]. (2009) (21)
Decreased production of interferon in whole blood cultures derived from patients with psoriasis. (1988) (21)
Brain‐derived neurotrophic factor is increased in serum and skin levels of patients with chronic spontaneous urticaria (2011) (21)
Intermittent BRAF‐inhibitor therapy is a feasible option: report of a patient with metastatic melanoma (2014) (21)
Chronic urticaria: assessment of current treatment (2005) (21)
Does Basal Cell Carcinoma Belong to the Spectrum of Sorafenib-Induced Epithelial Skin Cancers? (2010) (21)
Detection of circulating immune complexes in patients with atopic dermatitis and psoriasis. (1986) (20)
Analysis of the phenotype and cytokine pattern of blood- and skin-derived nickel specific T cells in allergic contact dermatitis. (1997) (20)
Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid. (2017) (20)
Childhood atopic dermatitis—Brain‐derived neurotrophic factor correlates with serum eosinophil cationic protein and disease severity (2016) (20)
Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors (2013) (20)
The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe (2005) (20)
Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response. (2004) (19)
Exotic food allergy: anaphylactic reaction to lychee. (2007) (19)
[The impact of food allergy in patients with atopic dermatitis]. (2003) (19)
Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo. (1997) (19)
Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis (2021) (18)
11q23 allelic loss is associated with regional lymph node metastasis in melanoma. (2000) (18)
Position statement: topical calcineurin inhibitors in atopic dermatitis (2018) (17)
Pirfenidone‐induced severe phototoxic reaction in a patient with idiopathic lung fibrosis (2016) (17)
Delayed‐type hypersensitivity to protamine as a complication of insulin therapy (2005) (17)
The basophil activation test is a helpful diagnostic tool in anaphylaxis to sesame with false‐negative specific IgE and negative skin test (2011) (17)
C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor. (1983) (16)
[Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)]. (2001) (16)
Erfolgreiche Therapie einer Haut- und Lungensarkoidose mit Fumarsäureestern (2004) (16)
Lymphocyte subsets, sIL2‐R and sICAM‐1 in blood during allergen challenge tests in asthmatic children (1993) (15)
Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma. (2013) (15)
The Role of Pimecrolimus Cream 1% (Elidel®) in Managing Adult Atopic Eczema (2007) (15)
Die Bedeutung der Nahrungsmittelallergie bei Patienten mit atopischer Dermatitis (2003) (14)
Differentiation between malignant and benign follicular adnexal tumours of the skin by DNA image cytometry (2002) (14)
Activation of human polymorphonuclear neutrophilic granulocytes by immuno-modulating cytokines: an ultrastructural study. (1989) (14)
PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo (1999) (14)
[Neurophysiology of pruritus]. (2006) (14)
Platon's Erziehungslehre, als Pädagogik für die Einzelnen und als Staatspädagogik. Oder, dessen praktische Philosophie (14)
Flow cytometry reveals different lag times in rapid cytoplasmic calcium elevations in human neutrophils in response to N‐formyl peptide (1993) (13)
Cutaneous manifestations of Takayasu arteritis. (1996) (13)
Involvement of complement in atopic dermatitis. (1985) (13)
Chapter 7 – Atopic Dermatitis and Allergic Contact Dermatitis (2006) (13)
Evidence‐based therapy of chronic urticaria (2007) (13)
Alterations of stress-induced expression of membrane molecules and intracellular cytokine levels in patients with atopic dermatitis depend on serum IgE levels. (2004) (13)
Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3 (2005) (13)
Urtikaria: CME-Artikel (2014) (13)
[Complement activation in patients with chronic polyarthritis, measured by the level of complement fraction C3a in plasma]. (1984) (12)
[Specific immunotherapy]. (2006) (12)
[Cutaneous side effects of EGF-receptor inhibition and their management]. (2006) (12)
[Infections and chronic spontaneous urticaria. A review]. (2010) (12)
[Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens]. (2017) (11)
Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK‐571 on the elimination of cysteinyl leukotrienes in the rat (1991) (11)
Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature (2018) (11)
Topical Tacrolimus in Erosive Oral Lichen Planus: An Effective Treatment Approach § (2005) (11)
T‐helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal‐derived factor‐1α (CXCL12) (2004) (11)
Ein Beitrag zur Verbesserung und Erweiterung der Lidar-Signalverarbeitung für Fahrzeuge (2007) (11)
Erfolgreiche Lokaltherapie einer kutanen Sarkoidose mit Tacrolimus (2003) (11)
Interaction of granulocytes and endothelial cells upon stimulation with tumor necrosis factor-alpha: an ultrastructural study. (1990) (11)
[Successful treatment of skin and lung sarcoidosis with fumaric acid ester]. (2004) (11)
A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report (2016) (11)
TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5. (1994) (11)
DNA image cytometry in malignant and benign sweat gland tumours (2000) (11)
Spontaneous regression of melanoma with distant metastases - report of a patient with brain metastases. (2006) (11)
Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence. (1986) (10)
Absence of HHV‐8 DNA in hobnail hemangiomas (2002) (10)
Evaluation of C3A receptor expression on human leukocytes by the use of novel monoclonal antibodies (1998) (10)
Chronische Urtikaria im Kindesalter (2004) (10)
Airborne contact dermatitis from colophony: phototoxic reaction? (1989) (10)
Amikrobielle intertriginöse Pustulose bei Autoimmunerkrankungen – Eine neue Entität? (1998) (10)
Neue Therapieoptionen der Urtikaria und ihrer Subtypen (2004) (10)
NAHRUNGSMITTELADDITIVA UND NICHT-STEROIDALE ANTIPHLOGISTIKA : AUSLOSER VONPSEUDOALLERGISCHEN REAKTIONEN (1996) (10)
Human HMC-1 mast cells exclusively express the FcγRII subtype of IgG receptor (1996) (10)
Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients (2007) (10)
Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study (2012) (10)
[The role of eosinophilic granulocytes for the pathogenesis of atopic dermatitis /neurodermatitis. Eosinophilic products as markers of disease activity]. (1993) (9)
Ultrarush SIT in venom allergy (2000) (9)
Lower prevalence of lymphatic metastasis and poorer survival of the sentinel node-negative patients limit the prognostic value of sentinel node biopsy for head or neck melanomas (2014) (9)
Atopic dermatitis management with tacrolimus ointment (Protopic). (2003) (9)
[Specific immunotherapy in the treatment of atopic dermatitis]. (2007) (9)
Human cell adhesion molecule uvomorulin is differentially expressed in various skin tumors (1993) (9)
The chemokine network in eosinophil activation. (2001) (9)
[Successful topical treatment of cutaneous sarcoidosis with tacrolimus]. (2003) (9)
Parameters predicting prognosis in melanoma sentinel nodes. (2011) (9)
Alkaptonuric ochronosis: report of two affected brothers. (1997) (9)
Symptomatische Therapie der atopischen Dermatitis (2003) (9)
Das Hand‐Fuß‐Syndrom als Nebenwirkung der medikamentösen Tumortherapie – Klassifikation und Management (2010) (8)
Regulation of melanocortin 1 receptor in allergic rhinitis in vitro and in vivo (2016) (8)
Identification of aneuploidy in recurrent clear cell hidradenoma by DMA image cytometry (ICM‐DNA) (1997) (8)
[Clinical symptoms and diagnostic workup of allergic reactions on the oral mucosa]. (2012) (8)
Modulation of intercellular adhesion molecule 1 (ICAM-1) expression on the human mast-cell line (HMC)-1 by inflammatory mediators. (1996) (8)
Wertigkeit des zellulären Antigenstimulationstests (CAST) (1997) (8)
Evidence for a Birch Pollen–Specific Cutaneous T–Cell Response in Food–Responsive Atopic Dermatitis (1999) (8)
Association of birch pollen-related food-responsive atopic dermatitis with birch pollen allergen-specific T-cell reactions. (1999) (8)
Evidenzbasierte Therapie bei Urtikaria (2006) (8)
[Remission of an iatrogenic Kaposi sarcoma in a patient with myasthenia gravis after switching immunosuppressive therapy to the mTOR inhibitor everolimus]. (2012) (8)
[New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors]. (2008) (8)
Induction of granulocyte chemiluminescence by a mediator derived from human monocytes. (1986) (8)
Allergic contact dermatitis due to monovalent sensitization to the oxidation hair dye intermediate oxamitol (2-aminomethyl-p-aminophenol-2HCl) without cross-sensitivity to haptens of the para-group. (2000) (8)
Das SAPHO-Syndrom Fallbeschreibung von drei Patienten mit Akne conglobata und osteoartikulären Symptomen (1997) (8)
Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils. (2001) (8)
Recommendations for photopatch testing by the Photopatch Test Working Group of the German Contact Dermatitis Research Group (DKG) (2018) (8)
Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis (2004) (8)
Aktuelle Positionsbestimmung zur Bedeutung von Nahrungsmittelallergien und -unverträglichkeiten bei der Urtikaria (2006) (8)
Quantification of Eosinophilic Granule Protein Deposition in Biopsies of Inflammatory Skin Diseases by Automated Image Analysis of Highly Sensitive Immunostaining (1999) (8)
[Specific IgE to Staphylococcus aureus in patients with atopic dermatitis]. (1989) (7)
Eosinophil granulocytes: functional differences of a new isolation kit compared to the isolation with anti‐CD16‐conjugated MicroBeads (2009) (7)
S2k-Leitlinie Neurodermitis (atopisches Ekzem, atopische Dermatitis) – Kurzversion (2016) (7)
Klinische Symptomatik und Diagnostik allergischer Reaktionen der Mundschleimhaut (2012) (7)
[Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream]. (2010) (7)
The functional activity of basophil granulocytes is modulated by acute mental stress and sympathetic activation in vivo and in vitro. (2008) (7)
[Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab]. (2014) (7)
IgE-vermittelte Reaktionen auf Nahrungsmittel bei Neurodermitis (2000) (7)
Allergic inflammation: skin (1999) (7)
Spezifische Immuntherapie bei der Behandlung der atopischen Dermatitis (2007) (7)
Neue und seltener angewandte Therapieoptionen bei therapierefraktärem Handekzem (2008) (7)
Remission eines iatrogenen Kaposi-Sarkoms bei Myasthenia gravis nach Umstellung der Immunsuppression auf den mTOR-Inhibitor Everolimus (2012) (7)
Activation of human eosinophil effector functions by CC chemokines. (1999) (7)
EAACI/GA2LEN/EDF/WAO-Leitlinie für die Definition, Klassifikation, Diagnose und das Management der Urtikaria — konsentierte, deutschsprachige Übersetzung (2018) (7)
[Chronic bullous dermatosis in childhood. Association with salmonella enteritis]. (1995) (7)
Empfehlungen der Arbeitsgruppe „Photopatchtest“ der Deutschen Kontaktallergie‐Gruppe (DKG) zur Durchführung des Photopatchtests (2018) (7)
Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma? (2011) (7)
Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1 (2005) (7)
Postzosterische Granulome mit Nachweis von Varizella-zoster-Virus-DNA in den Granulomen (2001) (7)
Neues zur Urtikaria (2004) (6)
Urticaria and Angioedema (2020) (6)
The Spectrum of Urticaria (2002) (6)
Moderne Diagnostik und Therapie der Urtikaria (2007) (6)
Omalizumab in der Behandlung unterschiedlicher Urtikariasubtypen (2011) (6)
Pigmentierung des Gesichtes unter Therapie mit Terbinafin (2005) (6)
Infektfokus und chronische spontane Urtikaria (2010) (6)
Das Bart-Syndrom – Eigene Entität oder Variante einer Epidermolysis bullosa? (1997) (6)
Evidence for a Similar Cytokine Pattern Expressed in Allergic Contact and Atopic Dermatitis (2001) (6)
Unverträglichkeit der spezifischen Immuntherapie mit Hymenopterengift (2014) (6)
964 Dichotomy of blood and skin derived interleukin-4 producing nickel specific T-cells and restricted Vβ repertoire in allergic contact dermatitis (1996) (6)
Chemiluminescence response of polymorphonuclear leukocytes in atopic dermatitis. (1987) (6)
Inhibitory effect of sulfonated shale oils (ammonium bituminosulfonate) on the stimulation of neutrophilic granulocytes by the chemotactic tripeptide f-Met-Leu-Phe (2004) (6)
Intraepidermal neutrophilic dermatosis type of IgA pemphigus with circulating linear IgA disease antibodies associated with ulcerative colitis (2018) (6)
Decreased activity of acid alpha-glucosidase in a patient with persistent periocular swelling after infusions of hydroxyethyl starch. (1998) (6)
[Postherpetic erythema exsudativum multiforme with concomitant exacerbation of psoriasis vulgaris]. (1990) (6)
[Cellular in-vitro assays. Applicability in daily routine]. (2010) (6)
[New therapeutic strategies for the different subtypes of urticaria]. (2004) (6)
Subcellular mechanisms of eosinophil degranulation: the role of RANTES, interleukin-5 and tumor necrosis factor-alpha. (1995) (6)
Diagnostik bei Urtikaria (2006) (5)
Leitlinie: Akuttherapie anaphylaktischer Reaktionen (2007) (5)
Staphylococcal Exotoxins as Trigger Factors of Atopic Dermatitis (2002) (5)
Pathophysiological Role of Leukotrienes in Dermatological Diseases (2012) (5)
Aminooxypentane-RANTES Induces CCR3 Activation and Internalization of CCR3 from the Surface of Human Eosinophils (2001) (5)
[Bart syndrome--separate entity or a variant of epidermolysis bullosa?]. (1997) (5)
Dysregulation of TLR-2 induced effects in monocytes from patients with atopic dermatitis: Impact of the TLR-2 R753Q polymorphism (2007) (5)
[Giant keratoacanthoma in an immunocompetent patient with detection of HPV 11]. (2009) (5)
Cytokines in Atopic Eczema (1991) (5)
Pruritus bei Urtikaria (2010) (5)
[The role of cytokines for the pathogenesis of psoriasis]. (1993) (5)
Identification of novel biomarkers to distinguish bradykinin‐mediated angioedema from mast cell‐/histamine‐mediated angioedema (2021) (5)
[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. (1997) (5)
Pimecrolimus cream 1% provides effective long-term control of atopic dermatitis in infants (2004) (5)
[Activated granulocytes as producers of reactive oxygen species--their significance for inflammatory reaction]. (1990) (5)
Human HMC-1 mast cells exclusively express the Fc gamma RII subtype of IgG receptor. (1996) (5)
[Chronic urticaria in childhood]. (2004) (5)
[Trigeminotrophic ulceration of the ala nasi in Wallenberg syndrome]. (2000) (5)
T-Cell function in atopic dermatitis controlled examination of Concanavalin A dose-response relations in cultured lymphocytes (1978) (5)
Reply to Sabato V et al “Surface expression of MRGPRX2 expression on resting basophils: An area of controversy” (2020) (5)
[Amicrobial intertriginous pustulosis in autoimmune diseases--a new entity?]. (1998) (5)
[Urticaria … and treatment fails]. (2013) (5)
[Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases]. (2009) (5)
Allelic loss at the p73 locus (1p36.33) is infrequent in malignant melanoma (1999) (5)
Zum Benefit der Patienten: Die Schildwächterlymphknotenentfernung (2011) (4)
Lokalisierte Infektion mit dem Kuhpocken-/Katzenpockenvirus Aktuelles zur Epidemiologie, Diagnostik und Therapie (1997) (4)
Pimecrolimus for the treatment of atopic dermatitis (2005) (4)
Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment (2009) (4)
Placeboeffekt in Studien zur allergenspezifischen Immuntherapie mit Inhalationsallergenen (2017) (4)
[Urticaria. Sometimes IgE-mediated?]. (2013) (4)
[Erythema elevatum and diutinum in Crohn disease]. (1996) (4)
[Atopic dermatitis: The hygiene hypothesis: Prevention through helminth infections?]. (2006) (4)
Elevated levels of soluble CD8 antigen in sera of patients with psoriasis — a possible sign of suppressor/cytotoxic T-cell activation (2004) (4)
Differential Diagnosis of Atopic Eczema (2006) (4)
Detection of complement activation in human serum using C5S-Induced chemiluminescence of human granulocytes (2004) (4)
Cutaneous Side Effects of New Antitumor Drugs (2012) (4)
Gewebeeosinophilie und lokale Deposition von Eosinophilen-spezifischen Granulaproteinen Regulation und Bedeutung für die Entzündungsantwort bei der atopischen Dermatitis und anderen entzündlichen Dermatosen (1998) (4)
Dupilumab in eosinophilic cellulitis (Wells’ syndrome) – case report of a potential new treatment option (2021) (4)
Hexadaktylie an Hand und Fuß bei einem Patienten mit Basalzellnävussyndrom (2002) (4)
[Current position of the role of allergic and non-allergic food hypersensitivity in urticaria]. (2006) (4)
Granulocyte-activating mediators (GRAM) (1987) (4)
Zelluläre In-vitro-Allergiediagnostik (2010) (4)
Stationäre medizinische Rehabilitation bei erwachsenen Patienten mit atopischer Dermatitis (2006) (4)
Die generalisierte Tendomyopathie, ein Syndrom im Rahmen der Atopie? (1984) (4)
Spezifische Immuntherapie (SIT) bei atopischer Dermatitis und Nahrungsmittelallergie (2008) (4)
Trigeminotrophe Ulzeration des Nasenflügels bei Wallenberg-Syndrom (2000) (4)
Riesenkeratoakanthom bei einem immunkompetenten Patienten mit Nachweis von HPV 11 (2009) (4)
Aktualisierung„ Systemtherapie bei Neurodermitis“ zur S2k‐Leitlinie Neurodermitis (2021) (4)
Focal neurological signs and symptoms induced by interferon‐alpha in two patients with malignant melanoma (1997) (4)
[Post-zoster granuloma with detection of varicella zoster virus DNA in the granulomas]. (2001) (4)
In-vitro Diagnostik der Acetylsalicylsäure-Pseudoallergie (1998) (4)
Die Arbeitsgemeinschaft Allergologie in der DDG (2014) (3)
Reactive oxygen release. (2000) (3)
Effect of Ca-panthotenate on human granulocyte oxidative metabolism. (1991) (3)
[For the benefit of the patient: the sentinel node excision]. (2011) (3)
Distinct Amplification of the C5a‐Receptor Pathways in Normodense and Hypodense Eosinophils of Patients with Atopic Dermatitis (2001) (3)
[The Working Group on Allergology in the DDG]. (2014) (3)
Erfolgreiche Therapie des IgA-Pemphigus vom subkorneal pustulösen Typ (2004) (3)
Successful treatment of an angiosarcoma of the head – options for systemic therapy (2011) (3)
Erfolgreiche symptomatische Therapie einer Epidermodysplasia verruciformis mit Imiquimod 5% Creme (2010) (3)
Urtikaria … und die Therapie versagt! (2013) (3)
Kutane Nebenwirkungen der medikamentösen Tumortherapie (2011) (3)
Cutaneous leishmaniasis (Aleppo boil): successful treatmentwith topical paromomycin (Humatin®) (2000) (3)
[Specific immunotherapy. Hyposensitization with allergens]. (2004) (3)
Evidenzbasierte Therapie der chronischen Urtikaria (2007) (3)
Hemorrhagic rash on the legs (2021) (3)
Neue Aspekte in der Diagnostik der chronischen Urtikaria (1998) (3)
[Tissue eosinophilia and local deposition of eosinophil-specific granule proteins. Regulation and significance for inflammatory response in atopic dermatitis and other inflammatory dermatoses]. (1998) (3)
Lyophylisierte Graspollentablette zur sublingualen Immuntherapie bei Graspollenallergie : aktueller Wissensstand und Ergebnisse des Entwicklungsprogramms eines neuen Präparats (2008) (3)
[Malignant melanoma of the skin. Pathogenesis, clinical aspects and prognosis]. (2000) (3)
Der Einfluß infektiöser Mikroorganismen auf den Verlauf der atopischen Dermatitis (2002) (3)
[Hexadactyly of hand and feet in a patient with basal cell nevus syndrome]. (2002) (2)
Symposium 7: Zelluläre In-vitro-Diagnostik (2007) (2)
Immunological aspects of allergic inflammation: eosinophils (2000) (2)
Alkaptonuric ochronosis: brothers Report of two affected (1997) (2)
Recurrent neutrophilic panniculitis secondary to bacterial cystitis. (2007) (2)
Different stress-induced membrane molecule profile of circulating lymphocytes in patients with psoriasis and healthy controls (2006) (2)
[Specific immunotherapy (SIT) in atopic dermatitis and food allergy]. (2008) (2)
13 – Atopic dermatitis and allergic contact dermatitis (2012) (2)
Effect of tumour necrosis factor alpha in vivo on human granulocyte oxidative metabolism (2004) (2)
Continuous clinical efficacy and progressive immunological effect of long-term specific immunotherapy with the ALK grass allergen tablet : Findings from a 3-year randomised adult trial (2008) (2)
Psychopharmakatherapie bei Pruritus (2012) (2)
[Pathogenesis of atopic dermatitis]. (1985) (2)
Granulocyte Mediator Release in Pseudo-allergic Reactions (1991) (2)
The Sequence of Stimuli Determines the Amount of IL-12 Produced by Human Monocytes (2001) (2)
Chemiluminescence response of human B-cell lines. (1987) (2)
Modulation of eosinophil effector functions: the potential role of monoclonal antibodies and chemokine receptor antagonists. (2000) (2)
Longitudinal Study of Sublingual Immunotherapy with SQ Standardized Grass Allergen Tablet - Interim Safety Results (2006) (2)
Hämatogenes allergisches Kontaktekzem nach oraler Nickelexposition (2009) (2)
[Squamous cell carcinoma developing in oral lichen planus]. (2013) (2)
Das unilaterale laterothorakale Exanthem : Eine charakteristische Hauterkrankung im Kindesalter (1996) (2)
[Modern diagnosis and treatment of urticaria: five case reports]. (2007) (2)
Characterization of Specific T-Cell Responses to Food Antigens in Atopic Eczema (1997) (2)
Kontaktallergie und Atopie (2011) (2)
Erythema elevatum et diutinum bei Morbus Crohn Klinischer Verlauf als Hinweis einer gemeinsamen Ätiologie? (1996) (2)
[Gender aspects in angioedema]. (2019) (2)
Urtikaria (2014) (2)
Chronisch bullöse Dermatose des Kindesalters Assoziation mit einer Salmonellen-Enteritis (1995) (2)
Kutane und pulmonale Sarkoidose (2012) (2)
Erfolgreiche Therapie des Pemphigus foliaceus mit Rituximab (2009) (2)
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]. (2013) (2)
Genetics of Cutaneous Malignant Melanoma (1999) (2)
Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma. (2007) (2)
ZYTOKINE ALS MEDIATOREN ALLERGISCHER ORGANREAKTIONEN (1997) (2)
Der histologische Status des Sentinel‐Lymphknotens ist der wichtigste Prognosefaktor bei Melanomen ≥4 mm Tumordicke (2008) (2)
Localized subepidermal blistering: not always bullous pemphigoid but a diagnostic challenge (2017) (2)
[Unclear pruritic and urticarial skin inflammation. Bed bug attack]. (2013) (2)
C3a —but not C3a-desarg— is a potent activator of the respiratory burst in human eosinophils (1993) (1)
Rückgang nicht‐melanozytärer Hauttumoren nach Umstellung der Immunsuppression auf mTOR‐Inhibitoren bei organtransplantierten Patienten (2014) (1)
PhotoDerm — eine Alternative zur Lasertherapie? (1998) (1)
[Cutaneous side effects of medical tumor therapy]. (2011) (1)
CAST-ELISA bei Intoleranzreaktionen (2000) (1)
Sublingual grass tablet immunotherapy shows a progressive immunological effect (2007) (1)
[Anaphylaxis to insect stings]. (2014) (1)
Granulocyte-activating mediators (GRAM): III. Further functional characterization of monocyte-derived GRAM (2004) (1)
Hereditärer C1-Esterase-Inhibitor-Mangel Typ I Divergenz klinischer Symptomatik und laborchemischer Befunde (2001) (1)
Differential expression of ICAM-1 in the human mast cell line HMC-1 (1994) (1)
Impact of desloratadine on signs, symptoms, and quality of life measures of chronic idiopathic urticaria (CIU) in clinical practice* (2003) (1)
Neue Therapieoptionen der Urtikaria und ihrer Subtypen : Urtikaria (2004) (1)
22 Final results of two randomized adjuvant trials of DeCOG (2004) (1)
Eosinophile fasziitis (Shulman syndrom). Kommentar (1998) (1)
Diagnostik blasenbildender Autoimmundermatosen an deutschen Hautkliniken (2012) (1)
Release of Sulfidoleukotrienes In Vitro: A Novel test system in the Diagnosis of Pseudo-Allergy to Acetylsalicylic Acid (1997) (1)
[Comments on the article by B.M. Henz and T. Zuberbier: "Urticaria--new developments and perspectives". Der Hautarzt (2000) 51:302-308]. (2001) (1)
[The epidermal Langerhans cell: watch post of the immune system in relation to the outside world]. (1992) (1)
Provokationsfaktoren der Neurodermitis/atopischen Dermatitis (1998) (1)
[Antidepressant drugs : a reasonable therapy for pruritus?]. (2012) (1)
[Facial pigmentation following therapy with terbinafine]. (2005) (1)
[Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease]. (2009) (1)
Pathophysiological Role of Leukotrienes in Dermatological DiseasesTherapeutic Implications (2001) (1)
[Value of the cellular antigen stimulation test (CAST)]. (1997) (1)
SEB-Oktapeptide induzieren eine enterotoxinspezifische T-Zellantwort bei atopischer Dermatitis (2006) (1)
T Cells in Atopic Dermatitis (2002) (1)
Spezifische Immuntherapie (2004) (1)
A novel interleukin stimulating free radical production by granulocytes. (1987) (1)
Anaphylaxie auf Insektenstiche (2014) (1)
Atopische Dermatitis: Hygiene-Hypothese (2006) (1)
Rationelles diagnostisches Vorgehen bei der chronischen Urtikaria (2000) (1)
[Successful treatment of subcorneal pustular type of IgA pemphigus]. (2005) (1)
The Role of Environmental Factors in the Provocation of Atopic Dermatitis (1999) (1)
Spezifische Immuntherapie. Hyposensibilisierung (2008) (1)
Histamine content of human eosinophil granulocytes (1999) (1)
IMMUNOLOGISCHE BEFUNDE BEI ATOPISCHER DERMATITIS (1998) (1)
Genderaspekt bei Angioödemen (2018) (1)
Immunologic Alterations in Atopic Eczema - Role of Cytokines? (1991) (1)
[Evidence-based treatment of urticaria]. (2006) (1)
The authors reply (2002) (1)
[Hereditary C1 esterase inhibitor deficiency type I. Divergence of clinical symptoms and laboratory chemical findings]. (2001) (1)
Sustained, disease-modifying effect of grass allergy tablet immunotherapy 1 year after a 3-year treatment period (2009) (1)
[Der Hautarzt will be Die Dermatologie : Title change of your journal]. (2022) (0)
[Significance of T4 cells in pollinosis and colitis]. (1997) (0)
Potent Anti-Inflammatory Effects of Tetracyclines on Human Eosinophils (2021) (0)
Occupational allergic contact dermatitis to cresyl glycidyl ether (CGE). (2007) (0)
Abstracts, 12th Symposium of the Working Group on Insect Venom Allergy, German Society of Allergy and Clinical Immunology (DGAKI), Frankfurt, Germany, November 20/21, 2020 (2020) (0)
CXCR1 and CXCR2 on Human Eosinophils The Biologic Role of Interleukin-8: Functional Analysis and Expression of (2013) (0)
[Modulation of the oxidative metabolism of granulocytes by nonsteroidal anti-inflammatory agents]. (1987) (0)
[The 2011 winner is? Springer Prize for Dermatology]. (2011) (0)
Contents Vol. 173, 2017 (2017) (0)
Down-regulation of CC chemokine receptor 3 protein and mRNA in human eosinophils mediated by IL-3 (2002) (0)
P97 Follicular and cystic eruptions under sorafenib therapy (2010) (0)
[Systemic therapy of atopic dermatitis]. (2003) (0)
Subject Index Vol. 205, 2002 (2002) (0)
Characterization of the receptors for the CXC chemokine IL-8 on human eosinophils (1998) (0)
Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) inhibit eosinophil apoptosis in atopic dermatitis (2003) (0)
Regulation of actin-polymerization in human eosinophils by chemotactic mediators — “Priming”-effect of IL-5 and GM-CSF (1993) (0)
Bristol Cup Posters: Summaries of Posters (2006) (0)
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. (2003) (0)
[Localized cowpox/cat pox virus infection. Aspects of epidemiology, diagnosis and therapy]. (1997) (0)
Neurotrophins exert immunomodulatory functions on peripheral blood eosinophils in atopic dermatitis (2008) (0)
CXC chemokine receptor 4 (CXCR4) on human eosinophils: Studies on constitutive and cytokine-dependent expression (2002) (0)
Functional expression and regulation of the C5a-receptor on human dendritic cells (2000) (0)
Burst in Human Eosinophils Fibroblasts and Its Activation of the Respiratory Cutting Edge: Detection of MCP-4 in Dermal (1998) (0)
[Pathogenesis of atopic dermatitis]. (1985) (0)
Interleukin-10 Is expressed by dermal fibroblasts but not exhibiting regulatory effects on human eosinophils (2002) (0)
Acknowledgement to Referees for Dermatology 2004 (2004) (0)
The human basophil – a novel target of the neuropeptide alpha‐melanocyte‐stimulating hormone (2008) (0)
Cloning and functional characterization of cynomolgus monkey (Macaca fascicularis) CC Chemokine Receptor 1 (2005) (0)
Newsletter ILDS No 15 (2010) (0)
Subject Index Vol. 209, 2004 (2004) (0)
[Cell biology and function of eosinophilic granulocytes in immunologic inflammation]. (1994) (0)
SUNDAY, SEPTEMBER 25TH 2011 151. Mechanisms of allergic inflammation of the airways (2011) (0)
Staphylococcal alpha toxin induces IFN-γ in skin and blood derived T cells of patients with atopic dermatitis (2004) (0)
Protein and mRNA in Human Eosinophils IL-3 Induces Down-Regulation of CCR 3 Proudfoot and Jörn Elsner (2001) (0)
MCP-4 is a potent CC-chemokine signalling through distinct human eosinophil receptors used as HIV-1 viral entry cofactors (1997) (0)
Atopic Dermatitis and Infections (2008) (0)
Acknowledgement to Referees for Dermatology 2002 (2002) (0)
21. Mainzer Allergie-Workshop (2009) (0)
Alpha-melanocyte stimulating hormone potentially inhibits basophil activation, indicating a novel function of this neuropeptide in airway allergy (2011) (0)
[Thanks to Prof. Dr. Michael Meurer : Editors and publisher thank the long-serving editor of the journal Der Hautarzt]. (2020) (0)
Role and mechanisms of eosinophil apoptosis in atopic dermatitis (2000) (0)
P90 Remission of iatrogenic Kaposiʼs sarcoma after switch of immunosuppressive regimen to everolimus in a patient with myasthenia gravis (2010) (0)
Activation of human eosinophils by CC chemokine eotaxin is inhibited by gelatinase B (MMP-9) (2003) (0)
The effect of the chemokine antagonist Met-RANTES on human eosinophils (1998) (0)
Antioxidants are potent inhibitors of spontaneous and induced bosinophil apoptosis (1998) (0)
Modifications at the N-terminus of C3a abolish its biologic function a study using the phage display technique (2002) (0)
[Allergic contact dermatitis and atopy]. (2011) (0)
[Severe hematogenous contact dermatitis after oral nickel exposition]. (2009) (0)
Contents Vol. 205, 2002 (2002) (0)
Langerhans cell histiocytosis mimicking prurigo nodularis (2020) (0)
The Journal’s Appreciation (1998) (0)
Thanks to Prof. Dr. Michael Meurer (2020) (0)
Interleukin-12 (P70) production by human monocytes is suppressed after preincubation with LPS or stimulation in the presence of C5A (1998) (0)
Eosinophil and neutrophil granulocytes. Discussion (1993) (0)
Effect oftheleukotriene receptor antagonists FPL55712, LY 163443, andMK-571on theelimination ofcysteinyl leukotrienes intherat (1991) (0)
Diagnostik I (2011) (0)
Curriculum Allergologie (2000) (0)
Symposium 14: Psychische Aspekte in der Allergologie (2007) (0)
Newsletter No. 10/2010 (2010) (0)
The eosinophil: What is it's role in atopic dermatitis (1998) (0)
Effects of Ultraviolet (UV) Light on Inflammatory Skin Disease (1992) (0)
Neurotrophins have a functional role on eosinophils in atopic dermatitis (2004) (0)
A rare case of neuro‐ and otosyphilis in secondary syphilis (2021) (0)
P073. Dermatological follow-up of patients with non melanoma skin cancer after solid organ transplantation switched to an mTOR inhibitor (2011) (0)
Contents Vol. 209, 2004 (2004) (0)
Insektengiftallergie — Anti-IgE-Therapie (2007) (0)
The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial (2008) (0)
[Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide]. (2001) (0)
Contents Vol. 161, No. 4, 2013 (2013) (0)
P25 Prognostic value of SLN biopsy in malignant melanoma of the head/neck in comparison to trunk and extremities (2010) (0)
[Pathogenesis of atopic dermatitis]. (1991) (0)
Basic Mechanisms in Allergic Disease (2016) (0)
The improvement in disease specific quality of life is sustained 1 year after completion of 3 years treatment with the a grass allergen immunotherapy tablet (2009) (0)
Immunologie I (2011) (0)
Exotic Food Allergy: Anaphylactic Reaction (2007) (0)
Protein and mRNA in Human Eosinophils IL-3 Induces Down-Regulation of CCR3 (2013) (0)
The T-cell chemotaxin rantes is more than a chemokine — Characterization of its effect on human eosinophil oxidative metabolism (1993) (0)
Front & Back Matter (2012) (0)
In Honour of Paul Kallós (1987) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
Reply to N. Rompoti et al. (2013) (0)
Basic Mechanisms in Allergic Disease Title : Human Basophils are Differentially Activated by and are a Source of IL-31 Running title : IL-31 activates human basophils (2016) (0)
Neuroimmunology and Itch of Atopic Dermatitis (2011) (0)
Reply to assessment of capsular melanoma cell deposits in sentinel lymph nodes (2011) (0)
Evaluation of criteria in sentinel nodes of melanoma patients that predict involvement of non-sentinel nodes (2006) (0)
Prospective Malignancy in recurrent Clear Cell Hidradenoma identified by DNA Image Cytometry (ICM-DNA): 67 (1997) (0)
[In appreciation of Professor Hans F. Merk : Editorial board and publisher bid farewell to the long-serving editor of the journal Der Hautarzt]. (2021) (0)
[Inpatient rehabilitation of adults with atopic dermatitis]. (2006) (0)
Contents, Vol. 82, 1987 (1987) (0)
[Not Available]. (2016) (0)
[2015 Springer Prize for Dermatology]. (2015) (0)
11 q 23 Allelic Loss Is Associated with Regional Lymph Node Metastasis in Melanoma 1 (2000) (0)
Induction ofHumanGranulocyte Chemiluminescence byBacterial Lipopolysaccharides (1987) (0)
eosinophils but not by neutrophils Surface and mRNA expression of the CD52 antigen by human (2011) (0)
Differential Activation of CC Chemokine Receptors by (2000) (0)
Sublingual immunotherapy with standardized quality grass allergen tablets: results of the development program (2008) (0)
Erratum (1991) (0)
Unmet Needs in Urticaria (2007) (0)
Contents Vol. 227, 2013 (2014) (0)
Role and contribution of viral respiratory infections to asthma. Discussion (1993) (0)
Modulation of granulocyte oxidative response by recombinant interferon alpha 2 and gamma. (1986) (0)
Allelic loss of a defined chromosomal region of the long arm of chromosome 11 in sporadic malignant melanoma progression: 462 (1997) (0)
P66 Successful treatment of metastasizing squamous cell carcinoma with cetuximab (2010) (0)
Therapeutic use of erythropoietin in dermatooncology (2007) (0)
Testicular Torsion in the Absence of Severe Pain: Considerations for the Pediatric Surgeon (2021) (0)
[19th Progress in Allergology, Immunology and Dermatology Congress in Davos. Chronic urticaria treatable in a large percentage of cases]. (2003) (0)
Is staphylococcal alpha-toxin a critical pathogenetic factor of atopic dermatitis in highly atopic individuals? (2007) (0)
Pathway the p 44 / 42 Mitogen-Activated Protein Kinase CD 40 Ligand : Evidence for Involvement of Suppression of IL-12 Production by Soluble (2002) (0)
Randomized P hase I II S tudy o f T emozolomide V ersus Dacarbazine i n t he T reatment o f P atients W ith A dvanced Metastatic M alignant M elanoma (2000) (0)
Refinement of two distinct regions of allelic loss of the long arm of chromosome 11 in malignant melanoma (1998) (0)
Iconography : Alkaptonuric ochronosis: Report of two affected brothers (2011) (0)
21 Therapie allergischer Erkrankungen mit monoklonalen Antikörpern (2002) (0)
9 Immunsystem der Bronchien (2002) (0)
Molekulare und immunologische Grundlagen allergischer Erkrankungen (1998) (0)
16 Klinisches Monitoring der Entzündungsreaktion in der HNO (2002) (0)
Entzündliche Dermatitiden (2011) (0)
Anaphylaxie und Insektengiftallergie (2011) (0)
DNA-Immunstimulation: Ein neuer Ansatz zur Therapie allergischer Erkrankungen (2003) (0)
Der eosinophile Granulozyt (1999) (0)
Stellungnahme zur Arbeit von B. M. Henz und T. Zuberier:¶“Urtikaria – Neue Entwicklungen und Perspektiven”Der Hautarzt (2000) 51: 302–308 (2001) (0)
14 Verlaufsbeobachtung des Asthma bronchiale (2002) (0)
Ex-vivo-Parameter von Überempfindlichkeitsreaktionen (2000) (0)
Seltene Nahrungsmittelallergien: mit IgE auf Kurs kommen (2018) (0)
DNA-Bildzytometrie (ICM-DNA) als adjuvante Methode zur Dignitätseinschätzung von Schweißdrüsentumoren (2000) (0)
Nicht-melanozytäre Hauttumoren treten nach Umstellung der Immunsuppression auf mTor-Inhibitoren seltener auf - eine Fallserie von 12 organtransplantierten Patienten (2011) (0)
Erythema nodosum leprosum unter Chemotherapie Erfolgreiche Behandlung mit Thalidomid (2001) (0)
Anaphylaktische Reaktion auf Cefazolin bei guter Verträglichkeit von Penicillin, Amoxicillin und einzelnen anderen Cephalosporinen (2008) (0)
Etwa die Hälfte der Patienten mit einer EV entwickelt im Verlauf kutane Malignome (2010) (0)
13 Pathophysiologie der allergischen Spättypreaktion (2002) (0)
Symposium 1: Atopisches Ekzem (2007) (0)
Europäischer Facharzt ante portas (2004) (0)
Akutes Auftreten einer eosinophilen Dermatitis nach COVID-19 Impfung mit BNT162b2 (Comirnaty) (2023) (0)
15 Monitoring allergischer Reaktionen in der Dermatologie (2002) (0)
Spezifische Immuntherapie (2006) (0)
Labelfreier Nachweis von DNA für die Virusdetektion (2011) (0)
Stress-induzierte Veränderungen von T-Helfer und Natürlichen Killerzellen bei Psoriasis und gesunden Kontrollen (2005) (0)
Plattenepithelkarzinom auf dem Boden eines Lichen ruber mucosae (2013) (0)
Serologische Risikoindikatoren (2011) (0)
Gibt es eine intrinsische Form der atopischen Dermatitis? (2000) (0)
Der Hautarzt wird zu Die Dermatologie (2022) (0)
Ungewöhnlich starkes allergisches Kontaktekzem auf Inhaltsstoffe einer schwarzen Lederbörse (2008) (0)
Notfälle in der Allergologie : Akuttherapie der Anaphylaxie (2008) (0)
8 Physiologie und Immunsystem der Nasenschleimhaut (2002) (0)
Insektengiftallergie im Kindesalter (2017) (0)
Zu allergischen Entzündungsreaktionen der Haut (2002) (0)
6 Komplementsystem und Lipidmediatoren (2002) (0)
12 Allergische Reaktion vom Soforttyp (2002) (0)
Therapeutischer Einsatz von Erythropoetin in der Dermatoonkologie (2007) (0)
Kontaktallergie auf Dentalmaterialien (2012) (0)
1 Das menschliche Immunsystem (2002) (0)
4 Monozyten, Makrophagen und dendritische Zellen (2002) (0)
Klinische Allergologie (2002) (0)
Intravaskuläre B-Zell-Lymphome (2008) (0)
Erfolgreiche Therapie eines Angiosarkoms des Kopfes – Systemische Therapieoptionen (2011) (0)
Sachwortverzeichnis Band 22, 1999 (1999) (0)
Die photodynamische Therapie aktinischer Präkanzerosen und Formen des Basalzellkarzinoms – ein innovatives Behandlungsverfahren in der Dermatologie (2003) (0)
Beeinflussung des Fettstoffwechsels durch systemische Vitamin‐A‐Derivate — Welche Empfehlungen leiten sich daraus für die dermatologische Praxis ab? (2011) (0)
Allelverlust von 11q23 als Progressionsmechanismus zur regionären Lymphknotenmetastasierung beim Melanom (2000) (0)
Dank an Herrn Professor Michael Meurer (2020) (0)
Beruflich bedingte Urtikaria, Angioödeme, Rhinokonjunktivitis und Asthma bronchiale bei multiplen Typ I-Sensibilisierungen gegenüber Nahrungsmitteln (2002) (0)
Therapie mit dem PhotoDerm®VL-Verfahren (1998) (0)
18 Therapie mit inhalatativen Clucocorticosteroiden (2002) (0)
Spezifische Immuntherapie (2011) (0)
Chronische Urtikaria : Ausdauer ist gefragt (2008) (0)
10 Immunsystem der Haut (2002) (0)
Anaphylaktische Reaktion auf Cefazolin bei guter Verträglichkeit von Panicillin, Amoxicillin und einzelnen anderen Cephalosporinen (2007) (0)
Springer-Preis für Dermatologie 2013 (2013) (0)
Therapie von Besenreisern mittels PhotoDerm VL und ScleroPLUS-Laser (1999) (0)
Miniaturisierter Laserscanner zur Umfelderfassung im Fahrzeugbereich (2004) (0)
Festvortrag: 19. Fortbildungskongress Davos — Vorträge (2003) (0)
Stellungnahme zur Arbeit von R. Gutzmer, R.A. Herbst, A. Kapp, J. Weiß: „Das SAPHO-Syndrom”Hautarzt (1997) 48:186–190 (1998) (0)
5 Das Zytokinnetzwerk (2002) (0)
Rheumatologie und Nephrologie (2000) (0)
Schildwächterlymphknotenbiopsie beim Melanom (2010) (0)
Durch Kuraufenthalt am Toten Meer lichtprovozierter disseminierter kutaner Lupus erythematodes (1989) (0)
Helicobacter-Infektion und Hauterkrankungen: Was ist wirklich dran? (2001) (0)
Medikamentös induzierte Vasculitis allergica: Der Protoneninhibitor Omeprazol als Antigen (2000) (0)
Stellungnahme zur Verordnung von Antihistaminika (2004) (0)
17. Mainzer Allergie-Workshop (2005) (0)
Einfluss der Zufütterung von Esparsette auf die Milchleistung und -zusammensetzung in einem Vollweidebetrieb (2018) (0)
Chronisch rezidivierende Urtikaria mit begleitenden Angioödemen bei Helicobacter-pylori-assoziierter Pangastritis und MALT-Lymphom des Magens (2000) (0)
Spezifische Immuntherapie bei atopischem Ekzem (2008) (0)
Juckreiz und urtikarielle Entzündungsreaktion der Haut unklarer Genese (2012) (0)
Bedeutung der T4-Zellen bei Pollinosis und Kolitis (1997) (0)
Erfolgreiche Therapie des Pemphigus foliaceus mit Rituximab : Bericht über 3 Patienten (Kasuistiken) (2009) (0)
Lokalisierte subepidermale Blasenbildung: nicht immer ein bullöses Pemphigoid, sondern eine diagnostische Herausforderung (2018) (0)
Triggerfaktoren der atopischen Dermatitis (2005) (0)
Allergische Entzündungen: Zur Pathophysiologie, Diagnostik und Therapie (2002) (0)
17 Klinisches Monitoring allergischer Entzündungsreaktionen in der Pädiatrie (2002) (0)
Apoptosemechanismen bei der atopischen Dermatitis (2002) (0)
Springer-Preis für Dermatologie 2017 (2017) (0)
Spezifische Immuntherapie (SIT) bei der atopischen Dermatitis (2010) (0)
Urtikaria und atopisches Ekzem (V 50–V 57) (2000) (0)
Exzellenter Allergologe und Allrounder (2021) (0)
Urtikaria und atopisches Ekzem (V 50–V 57) (2000) (0)
Herrn Professor Hans F. Merk zum Dank (2021) (0)
11 Neurogene Aspekte der allergischen Entzündungsreaktion (2002) (0)
Topical immunomodulators in the treatment of atopic dermatitis / Topische Immunmodulatoren bei der Behandlung der atopischen Dermatitis (2004) (0)
Erratum zu: Juckreiz und urtikarielle Entzündungsreaktion der Haut unklarer Genese. Cimicosis durch die Bettwanze (2013) (0)
Lymphozyten und Zytokine (V 09–V 14) (2000) (0)
3 Mastzellen und Basophile (2002) (0)
Führt Zufütterung von Esparsette zu einer höheren Effizienz bei eiweissreicher Herbstweide (2018) (0)
Pseudoallergie: Entität oder Fiktion? (2003) (0)
Dupilumab bei eosinophiler Zellulitis (Wells‐Syndrom) – Fallbericht einer möglichen neuen Therapieoption (2021) (0)
MHH-AZ – Comprehensive Allergy Center der Medizinischen Hochschule Hannover (2021) (0)
Aktuelles zur Nahrungsmittelallergie bei atopischer Dermatitis (2004) (0)
Möglichkeiten und Grenzen der zellulären In-vitro-Allergiediagnostik bei Arzneimittelüberempfindlichkeit mit klinischer Sofortreaktion (2013) (0)
7 T-Lymphozyten (2002) (0)
Immuntherapie der atopischen Dermatitis (2007) (0)
ResponsesIL-12: Implications for Control of T Cell Human Eosinophils Produce Biologically Active (1998) (0)
Modulation of granulocyte oxidative response by recombinant interferon α2 and γ (2004) (0)
Klinische In-vitro-Diagnostik (2011) (0)

This paper list is powered by the following services:

Other Resources About Alexander Kapp

en.wikipedia.org

What Schools Are Affiliated With Alexander Kapp ?

Alexander Kapp is affiliated with the following schools:

Alexander Kapp 's Academic­Influence.com Rankings

Why Is Alexander Kapp Influential?

Alexander Kapp 's Published Works

Published Works

Other Resources About Alexander Kapp

What Schools Are Affiliated With Alexander Kapp ?

Alexander Kapp 's AcademicInfluence.com Rankings